News Major shareholder announcement – BlackRock, Inc. Staff September 11, 2023 Iframe sync Post navigation Previous: Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Next: Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston More Stories Diagnostics Fitness News Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship Staff December 22, 2025 Cancer Diagnostics DNA News Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach Staff December 22, 2025 EHR Healthcare News KLAS Report Shows Strong Early Results for TrustCommerce Cloud Payments Staff December 22, 2025
